Tango Therapeutics News and Activities

Presence

Tango Therapeutics develops cancer medicines based on genetic targets. Its services include drug discovery and clinical development for pharmaceutical partners, healthcare providers, and patients with difficult-to-treat cancers.

Tango Therapeutics products and services overview:

Cancer therapies
Targeted medicines
Drug discovery
Clinical development
Research partnerships

Revenue: ~$28 million

Employees: 180

Headquarters: Boston, United States (USA)

Tango Therapeutics is one of the...

Tango Therapeutics is a company listed under the stock ticker TNGX (US).

Executives

View the org chart displaying its 35 main executives

Most searched biographies at Tango Therapeutics

Popular executive movements at Tango Therapeutics

Janice Kapty has joined the company as Senior Vice President, Corporate Strategy and Project Leadership (posted on April 16 2026).
Matthew Gall has joined the company as Chief Financial Officer (posted on April 16 2026).
Yen-Ching Chua will join the company as Chief Development Operations Officer on Jun. 1, 2026 (posted on April 16 2026).

Click here to view some more movements at Tango Therapeutics

Create your alert
to follow the executive moves at Tango Therapeutics.